[OA] What does androgenetic alopecia have to do with COVID-19?
Dear Editor
In late 2019, a novel coronavirus, subsequently named SARS‐CoV‐2 (COVID‐19), was first reported in Hubei province in China. Since it was first reported, a worldwide pandemic has ensued affecting more than 450 000 individuals as of March 2020. In the midst of the pandemic, epidemiological reports unveiled a disproportionate low rate of severe cases among adult females compared to adult males, 42% and 58%, respectively.1 Similarly, the rate of severe cases among pre‐pubescent children was exceptionally low at 0.6%.1 An explanation for the skewed prevalence of severe COVID‐19 infection in adult males has yet to be elucidated.
…
Goren A, McCoy J, Wambier CG, et al. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy [published online ahead of print, 2020 Apr 1]. Dermatol Ther. 2020;e13365. doi:10.1111/dth.13365 Error - Cookies Turned Off
[OA] Kroumpouzos G. Effects of 5-alpha reductase inhibitors on lung function: a reason for discontinuation during COVID-19 pandemic? [published online ahead of print, 2020 May 7]. Dermatol Ther. 2020;e13535. doi:10.1111/dth.13535 Error - Cookies Turned Off